Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideDGXQuest Diagnostics
FinDog View：Bullish
GILDGilead Sciences
FinDog View：Neutral
| Metric | DGX | GILD |
|---|
| Close | 251.82 | 170.68 |
| Market Cap | $27.7B | $213B |
| 1M | +8.04% | +14.51% |
| P/E (TTM) | 24.5 | — |
| Forward P/E | 19.9 | 22.0 |
| P/E 5-Yr Percentile | 91 | — |
| P/S | 2.3 | 7.0 |
| P/B | 3.6 | 17.9 |
| Dividend Yield | 2.10% | 3.98% |
| Latest Quarter Revenue | $3.1B | $8.3B |
| Revenue YoY | +10.0% | +6.8% |
| Gross Margin | 33.6% | 81.1% |
| Latest Quarter EPS | 2.78 | 1.94 |
| Avg Post-Earnings Move | ±1.7% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.95% | 2.57% |
| 90-Day Net Insider Buying | −$8.2M | −$15.9M |
DGX · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
